NewEdge Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Sell
8,219
-1,729
-17% -$459K 0.01% 863
2026
Q1
$1.09M Sell
9,948
-5,679
-36% -$809K ﹤0.01% 1456
2025
Q4
$1.87M Buy
15,627
+10,020
+179% +$1.68M 0.01% 1108
2025
Q3
$1.1M Sell
5,607
-6,627
-54% -$1.09M 0.01% 1353
2025
Q2
$1.11M Buy
12,234
+11,983
+4,774% +$947K 0.01% 1224
2025
Q1
$15K Sell
251
-224
-47% -$20.7K ﹤0.01% 2959
2024
Q4
$62.9K Buy
+475
New +$44.6K ﹤0.01% 2441

Other funds holding ALAB

NewEdge Advisors's ALAB Position: Q2 2026 in Review

NewEdge Advisors reduced its Astera Labs (ALAB) stake by 17% in Q2 2026, selling an estimated $459K and leaving 8,219 shares worth $3.97M. The position accounts for 0.01% of the portfolio, ranked #863.

NewEdge Advisors first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • NewEdge Advisors held 8,219 shares of Astera Labs worth $3.97M as of Q2 2026.
  • NewEdge Advisors sold 1,729 Astera Labs shares in Q2 2026, an estimated $459K.
  • Astera Labs made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #863 holding.
  • NewEdge Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.